Dr. Ranjit Roy Chaudhury Committee

Dr Ranjit Roy Chaudhury Committee was an expert committee constituted in 2014 to develop the guidelines and policy for the approval of new drugs, clinical trials, and banning drugs. The Indian government formed a committee under Prime Minister Narendra Modi to take these decisions. The Committee's main objective is to ensure that the science behind developing new drugs is backed and approved by sound scientific evidence.

What are clinical trials?

A clinical trial is research where human testing is done under controlled conditions. During clinical trials, one new drug is compared with another existing drug to judge its efficiency and efficacy of the new drug.

Why are clinical trials necessary?

Clinical trials are conducted to improve people's health and quality of life via new therapeutic approaches. Clinical trials are commonly used to approve new drug formulations, indications, and indications. The result of clinical trials is to determine whether the new drugs will be helpful, safe, and effective for patients compared to a placebo.

Clinical trials require the participation and cooperation of experienced healthcare professionals, people with disabilities, including ethnic patients, patients at risk, the general population, and institutional ethics committees.

☛ Also Read: Current Affairs Today

Significance of Ranjit Roy Chaudhury Committee

Ranjit Roy Chaudhury Committee was formed to ensure that every drug is developed with what it needs to be and by the time required. The committee will approve clinical trials and monitor the tests conducted across India and abroad. The main aim of this committee is to improve the quality of life for people.

Recommendations of Ranjit Roy Chaudhury Committee on Clinical Trials

1) The committee recommends that the accreditation process should be done transparently. There should also be a Department of Clinical Trials in every Medical College.

2) no clinical trials can be conducted on people under 18 years of age or pregnant women without the consent of the Ethics Committee. If the research project does not require the involvement of human subjects, then researchers cannot make use of family members or volunteers without the consent of an ethics committee.

3) All clinical trials must have informed consent from patients, meaning that patients must be informed about the trial before they consent to participate in it.

4) The trial should be conducted in a location that is well equipped and monitored by qualified medical professionals.

5) The trial must have a primary endpoint, and secondary endpoint, meaning that the main outcome of the research must be measured and there must be an objective way to measure this data.

6) Human subjects shall not be recruited or used in non-therapeutic experiments or clinical practices if they are willing to participate in these trials.

7) Participants who participate in clinical trials are entitled to information, compensation or benefits at the end of their participation in the study.

Ranjit Roy Chaudhury Committee has made several recommendations that will benefit the people of India. The committee has taken a lot of time to develop these valuable guidelines for conducting clinical trials and approval of new drugs.

FAQs on Ranjit Roy Chaudhury Committee

Q1. What is the Ranjit Roy Chaudhury Committee?

Ranjit Roy Chaudhury Committee is an expert panel set up by the Indian Government. The committee was established to formulate clinical trials and drug approval policies.

Q2. What is a clinical trial in the Ranjit Roy Chaudhury committee?

Clinical trials are a kind of research that involves human participants. The trial in the Ranjit Roy Chaudhury Committee aims to measure a drug's efficacy regarding patients, especially those vulnerable and at risk of medical conditions. Such trials will help improve patients' health and wellbeing over time.

Q3. What is the main objective of the Ranjit Roy Chaudhury committee?

The Ranjit Roy Chaudhury committee's purpose is to ensure that new drugs and clinical trials are approved in a way that integrates into good quality healthcare practices. The committee will also ensure that patients, especially those vulnerable and at risk of getting diseases, have access to essential medicines.

Q4. What are the recommendations of the Ranjit Roy Chaudhury committee?

The Ranjit Roy Chaudhury committee recommends that clinical trials should be conducted in a manner that will promote transparency and ethics. Trials should also adhere to Indian law and regulations. There should also be a Department of Clinical Trials in every Medical College and clinical trial guidelines for every hospital in India.